These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis. Cantarini L; Lopalco G; Selmi C; Napodano S; De Rosa G; Caso F; Costa L; Iannone F; Rigante D Autoimmun Rev; 2015 Feb; 14(2):90-7. PubMed ID: 25308531 [TBL] [Abstract][Full Text] [Related]
6. Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review. Vinit C; Georgin-Lavialle S; Theodoropoulou A; Barbier C; Belot A; Mejbri M; Pillet P; Pachlopnik J; Poignant S; Rebelle C; Woerner A; Koné-Paut I; Hentgen V Front Immunol; 2021; 12():744780. PubMed ID: 34858402 [TBL] [Abstract][Full Text] [Related]
7. Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network. Vitale A; Obici L; Cattalini M; Lopalco G; Merlini G; Ricco N; Soriano A; La Torre F; Verrecchia E; Insalaco A; Dagna L; Jaber MA; Montin D; Emmi G; Ciarcia L; Barneschi S; Parronchi P; Ruscitti P; Maggio MC; Viapiana O; Sota J; Gaggiano C; Giacomelli R; Sicignano LL; Manna R; Renieri A; Lo Rizzo C; Frediani B; Rigante D; Cantarini L Front Med (Lausanne); 2021; 8():668173. PubMed ID: 34307404 [No Abstract] [Full Text] [Related]
8. TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS. Rittore C; Méchin D; Sanchez E; Marinèche L; Ea V; Soler S; Vereecke M; Mallavialle A; Richard E; Duroux-Richard I; Apparailly F; Touitou I; Grandemange S Sci Rep; 2021 Feb; 11(1):4172. PubMed ID: 33603056 [TBL] [Abstract][Full Text] [Related]
9. Tumour necrosis factor signalling in health and disease. Holbrook J; Lara-Reyna S; Jarosz-Griffiths H; McDermott M F1000Res; 2019; 8():. PubMed ID: 30755793 [TBL] [Abstract][Full Text] [Related]
10. Recurrent fever and arthralgia as the presentation of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Chinese girl: a case report and review of the literature. Chen Y; Huang X; Zheng S; Zhu Z; Yang W; Liu J Clin Rheumatol; 2018 May; 37(5):1433-1438. PubMed ID: 29450850 [TBL] [Abstract][Full Text] [Related]
11. Inflammasome-Dependent Cytokines at the Crossroads of Health and Autoinflammatory Disease. Van Gorp H; Van Opdenbosch N; Lamkanfi M Cold Spring Harb Perspect Biol; 2019 Jan; 11(1):. PubMed ID: 29038114 [TBL] [Abstract][Full Text] [Related]
13. Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient. Ozen S; Demir S Paediatr Drugs; 2017 Aug; 19(4):303-311. PubMed ID: 28497352 [TBL] [Abstract][Full Text] [Related]
14. Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study. Gattorno M; Obici L; Cattalini M; Tormey V; Abrams K; Davis N; Speziale A; Bhansali SG; Martini A; Lachmann HJ Ann Rheum Dis; 2017 Jan; 76(1):173-178. PubMed ID: 27269295 [TBL] [Abstract][Full Text] [Related]
15. Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists' lens. Cattalini M; Soliani M; Lopalco G; Rigante D; Cantarini L Intern Emerg Med; 2016 Sep; 11(6):781-91. PubMed ID: 27221072 [TBL] [Abstract][Full Text] [Related]
16. Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome. Rigante D; Lopalco G; Vitale A; Lucherini OM; De Clemente C; Caso F; Emmi G; Costa L; Silvestri E; Andreozzi L; Iannone F; Galeazzi M; Cantarini L Clin Rheumatol; 2014 Sep; 33(9):1197-207. PubMed ID: 24935411 [TBL] [Abstract][Full Text] [Related]
17. Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation. Sanchez GA; de Jesus AA; Goldbach-Mansky R Rheum Dis Clin North Am; 2013 Nov; 39(4):701-34. PubMed ID: 24182851 [TBL] [Abstract][Full Text] [Related]
18. Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. Vitale A; Rigante D; Lucherini OM; Caso F; Muscari I; Magnotti F; Brizi MG; Guerrini S; Patti M; Punzi L; Galeazzi M; Cantarini L Mediators Inflamm; 2013; 2013():939847. PubMed ID: 23970817 [TBL] [Abstract][Full Text] [Related]
19. Monogenic autoinflammatory diseases: concept and clinical manifestations. Almeida de Jesus A; Goldbach-Mansky R Clin Immunol; 2013 Jun; 147(3):155-74. PubMed ID: 23711932 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study. Bulua AC; Mogul DB; Aksentijevich I; Singh H; He DY; Muenz LR; Ward MM; Yarboro CH; Kastner DL; Siegel RM; Hull KM Arthritis Rheum; 2012 Mar; 64(3):908-13. PubMed ID: 22006113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]